LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) has announced the appointment of Kip Crecca to its Scientific Advisory Board, marking a strategic enhancement of its leadership team with an experienced sales professional from the medical device industry.
Adam Levy, CEO of NEXGEL, expressed enthusiasm about the new appointment, stating, “We are thrilled to appoint Kip to our Scientific Advisory Board. He adds to our team a wealth of knowledge and experience as a top medical device sales professional.” Levy highlighted that Crecca’s expertise will be invaluable as NEXGEL advances its medical device and healthcare programs, emphasizing the importance of Crecca’s entrepreneurial spirit and innovative outlook in driving the company’s growth initiatives.
Kip Crecca, bringing over twenty years of experience in medical device sales and management, currently serves as the Vice President of North America Sales at MicroSurgical Technology. His role at MicroSurgical Technology involves overseeing the development of advanced surgical instruments and solutions. Additionally, Crecca holds a position on the Board of Directors at Ocular Science, a biotech company that focuses on innovative and cost-effective eye care products. His previous experience includes leadership positions with STAAR Surgical, Abbott Medical Optics, and Stryker Endoscopy.
Upon his appointment, Crecca remarked, “I am excited to join NEXGEL’s Scientific Advisory Board and collaborate with a talented group of individuals to support the development of new therapies leveraging the Company’s ultra-gentle, high-water-content hydrogels.”
With Crecca’s extensive background and strategic insight, NEXGEL aims to enhance its efforts in delivering innovative hydrogel solutions to improve patient care globally.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.